| Marga Schoch, OTR/L | |
|
6140 Woodside Executive Ct, Aiken, SC 29803-3820 | |
| (803) 642-0700 | |
| Not Available |
| Full Name | Marga Schoch |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 6140 Woodside Executive Ct, Aiken, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366846818 | NPI | - | NPPES |
| 4384 | Other | SC | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 4384 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marga Schoch, OTR/L 6140 Woodside Executive Ct, Aiken, SC 29803-3820 Ph: (803) 642-0700 | Marga Schoch, OTR/L 6140 Woodside Executive Ct, Aiken, SC 29803-3820 Ph: (803) 642-0700 |
News Archive
We classified ‘long-term' cannabis use as being regular, at least weekly, cannabis use for over 12 months. This is the period of time that's used in the DSM-IV psychiatric diagnostic manual to classify substance use disorders. In our study the average duration of at least weekly use was just over four and a half years.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to hGH-CTP, PROLOR's longer-acting version of human growth hormone for the treatment of growth hormone deficiency.
The American Society for Gastrointestinal Endoscopy (ASGE) has reacted with caution to claims of the benefits of computed tomography (CT) colonography, also referred to as virtual colonoscopy, compared to standard colonoscopy.
Celgene International Sàrl today announced that initial data from an investigator-initiated study of REVLIMID (lenalidomide) plus Rituxan (rituximab) in patients with newly diagnosed indolent B-cell non-Hodgkin's lymphoma (NHL) were presented at the annual meeting of the American Society of Clinical Oncology.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) application for its doxorubicin targeted conjugate compound, AEZS-108, in luteinizing hormone releasing hormone (LHRH) receptor positive urothelial (bladder) cancer.
› Verified 4 days ago
Mrs. Patricia Shoemake Luke, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Brookhaven Dr, Aiken, SC 29803 Phone: 803-641-2624 | |
David Michael Bernard, OTR/L, CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 690 Medical Park Dr, Aiken, SC 29801 Phone: 803-648-8344 | |
Elizabeth Noelle Hammond, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 181 Town Creek Rd, Aiken, SC 29803 Phone: 803-642-0700 Fax: 803-642-0588 | |
Michael Joseph Schwab, OT, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 550 Eastgate Dr, Aiken, SC 29803 Phone: 803-643-3694 | |
Holly Lynne Shurtleff, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 690 Medical Park Dr, Aiken, SC 29801 Phone: 803-293-4326 | |
Heather Leigh Raynack, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 690 Medical Park Dr, Aiken, SC 29801 Phone: 803-648-8344 | |
Jamie Holmes, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 21 Longwood Dr, Aiken, SC 29803 Phone: 803-522-5599 |